PROG
Price:
$0.8845
Market Cap:
$994.99K
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company develops targeted oral delivery of biotherapeutics, including PGN-600, an orally delivered liquid formulation of tofacitinib for the treatment of ulcerative colitis; and PGN-001, an orally delivered variant of adalimumab for the treatment of ulcerative colitis. It also develops systemic oral delivery of biotherapeutics, which include PGN-OB, a combination product of a variant of adalimumab and the Oral Biotherapeutics Delivery System (OBDM) for the treatment of inflammatory conditions; and PGN-OB2, a combination product of a GLP-1 receptor agonist and th...[Read more]
Industry
Biotechnology
IPO Date
2020-06-19
Stock Exchange
NASDAQ
Ticker
PROG
According to Biora Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 37.44M. This represents a change of -99.93% compared to the average of 56.44B of the last 4 quarters.
The mean historical Enterprise Value of Biora Therapeutics, Inc. over the last ten years is 2.52B. The current 37.44M Enterprise Value has changed 48.40% with respect to the historical average. Over the past ten years (40 quarters), PROG's Enterprise Value was at its highest in in the June 2024 quarter at 225.08B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
2.52B
Median
2.54B
Minimum
53.51M
Maximum
6.10B
Discovering the peaks and valleys of Biora Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 71.21%
Maximum Annual Enterprise Value = 6.10B
Minimum Annual Increase = -84.72%
Minimum Annual Enterprise Value = 53.51M
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | 53.51M | -84.72% |
| 2022 | 350.17M | -82.90% |
| 2021 | 2.05B | -32.42% |
| 2020 | 3.03B | -50.30% |
| 2019 | 6.10B | 71.21% |
The current Enterprise Value of Biora Therapeutics, Inc. (PROG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
817.10M
5-year avg
2.32B
10-year avg
2.52B
Biora Therapeutics, Inc.’s Enterprise Value is greater than Turnstone Biologics Corp. (-8062051.00), greater than Tvardi Therapeutics, Inc. (20.18M), less than Omega Therapeutics, Inc. (105.65M), greater than COSCIENS Biopharma Inc. (-393746.00), greater than Channel Therapeutics Corporation (11.15M), greater than Apexigen, Inc. (-5121682.00), greater than Kineta, Inc. (7.37M), greater than Neoleukin Therapeutics, Inc. (-52597315.00), greater than ESSA Pharma Inc. (-76434138.00), less than CervoMed Inc. (69.77M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -8062051.00 | $8.21M | |
| 20.18M | $41.37M | |
| 105.65M | $7.90M | |
| -393746.00 | $6.68M | |
| 11.15M | $8.90M | |
| -5121682.00 | $9.57M | |
| 7.37M | $7.05M | |
| -52597315.00 | $8.20M | |
| -76434138.00 | $9.52M | |
| 69.77M | $78.09M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biora Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biora Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Biora Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Biora Therapeutics, Inc. (PROG)?
What is the 3-year average Enterprise Value for Biora Therapeutics, Inc. (PROG)?
What is the 5-year average Enterprise Value for Biora Therapeutics, Inc. (PROG)?
How does the current Enterprise Value for Biora Therapeutics, Inc. (PROG) compare to its historical average?